Abt199

Dr. Younes on IPI-145 and ABT-199 in Lymphoid Malignancies 01:55
Dr. Younes on IPI-145 and ABT-199 in Lymphoid Malignancies OncLive 232 11 лет назад
Dr. John Seymour on the Efficacy of ABT-199 in High-Risk CLL 01:42
Dr. John Seymour on the Efficacy of ABT-199 in High-Risk CLL OncLive 1,378 11 лет назад
ABT199/Venetoclax Synergism with Thiotepa Enhances AML Cytotoxicity | Oncotarget 02:03
ABT199/Venetoclax Synergism with Thiotepa Enhances AML Cytotoxicity | Oncotarget Oncotarget 85 1 год назад
Combination studies with venetoclax (ABT-199), BCL-2 inhibitor, for non-Hodgkin lymphoma 04:15
Combination studies with venetoclax (ABT-199), BCL-2 inhibitor, for non-Hodgkin lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 410 9 лет назад
Side-effects profile of venetoclax (ABT-199) 03:53
Side-effects profile of venetoclax (ABT-199) Patient Power Europe 2,393 9 лет назад
Dr. Brown Gives an Overview of ABT-199 for the Treatment of CLL 02:04
Dr. Brown Gives an Overview of ABT-199 for the Treatment of CLL Targeted Oncology 348 11 лет назад
The use of venetoclax (ABT-199) in the treatment of CLL 01:35
The use of venetoclax (ABT-199) in the treatment of CLL VJHemOnc – Video Journal of Hematology & HemOnc 617 9 лет назад
Oncotarget | ABT199/Venetoclax in Acute Myeloid Leukemia Treatment 00:58
Oncotarget | ABT199/Venetoclax in Acute Myeloid Leukemia Treatment Oncotarget 37 3 года назад
What is Venetoclax? | Dana-Farber Cancer Institute 02:02
What is Venetoclax? | Dana-Farber Cancer Institute Dana-Farber Cancer Institute 2,227 9 лет назад
The first consultation before starting treatment with venetoclax (ABT-199) 02:02
The first consultation before starting treatment with venetoclax (ABT-199) Patient Power Europe 234 9 лет назад
Importance of Bcl-2-targeted therapies 02:52
Importance of Bcl-2-targeted therapies VJHemOnc – Video Journal of Hematology & HemOnc 112 9 лет назад
Mechanism of action of venetoclax (ABT-199) and its side effects 03:06
Mechanism of action of venetoclax (ABT-199) and its side effects VJHemOnc – Video Journal of Hematology & HemOnc 9,196 9 лет назад
Venetoclax in Higher-Risk MDS/AML 16:23
Venetoclax in Higher-Risk MDS/AML MDS Foundation, Inc. 814 4 года назад
Prof. John Gribben describes Deborah's clinical trial: venetoclax (ABT-199) plus obinutuzumab 02:49
Prof. John Gribben describes Deborah's clinical trial: venetoclax (ABT-199) plus obinutuzumab Patient Power Europe 437 9 лет назад
Overview of a promising new study of venetoclax in patients with CLL 03:40
Overview of a promising new study of venetoclax in patients with CLL VJHemOnc – Video Journal of Hematology & HemOnc 562 9 лет назад
Dr. Younes on IPI-145 and ABT-199 for Lymphoid Malignancies 01:58
Dr. Younes on IPI-145 and ABT-199 for Lymphoid Malignancies Targeted Oncology 159 10 лет назад
How venetoclax (ABT-199) targets and kills CLL cells 01:53
How venetoclax (ABT-199) targets and kills CLL cells Patient Power Europe 213 9 лет назад
Introducing venetoclax, a powerful new drug that may treat CLL 03:27
Introducing venetoclax, a powerful new drug that may treat CLL Patient Power Europe 1,223 9 лет назад
Bcl-2 Inhibition With ABT-199 in CLL, Lymphomas 06:43
Bcl-2 Inhibition With ABT-199 in CLL, Lymphomas OncLive 1,278 10 лет назад
Venotoclax (ABT-199/GDC-0199) i with Decitabine or Azacitidine in Patients with AML 04:16
Venotoclax (ABT-199/GDC-0199) i with Decitabine or Azacitidine in Patients with AML Oncology.TV 963 9 лет назад

Сейчас ищут